Trials / Completed
CompletedNCT06795594
Effectiveness of Cheek Acupuncture Therapy for Pain Control After Cesarean Delivery
Cheek Acupuncture Therapy Vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Beijing Tongren Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates whether cheek acupuncture therapy can alleviate postoperative pain in cesarean section patients and explores its mechanisms of action through a prospective randomized controlled clinical trial.
Detailed description
Pain control after cesarean delivery, if inadequately managed, can impact the prognosis of the mother and the health of the infant. There is an urgent need to explore safer, more effective, and straightforward non-pharmacological adjunctive interventions to alleviate the pain associated with cesarean section. Cheek acupuncture therapy is a green micro-acupuncture treatment that has shown significant improvement in various types of pain and holds great potential for relieving perioperative pain. To practice the concept of perioperative acupuncture medicine, this study aims to investigate whether cheek acupuncture therapy can alleviate postoperative pain in cesarean section patients and to explore the mechanisms by which it exerts its effects, through a prospective randomized controlled clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cheek acupuncture | Cheek Acupuncture |
| DRUG | sufentanil 2 µg/kg + ondansetron 0.2 mg/kg | The patient-controlled analgesia (PCA) pump held a solution of 2 µg/kg sufentanil and 0.2 mg/kg ondansetron in 100 ml. It infused 2 ml/hour continuously, allowing patients to self-administer an extra 2 ml bolus every 15 minutes if needed. For inadequate pain control, diclofenac sodium suppositories were used as rescue analgesia, depending on individual pain assessments and the requirement for extra relief. |
Timeline
- Start date
- 2025-01-05
- Primary completion
- 2025-03-10
- Completion
- 2025-03-10
- First posted
- 2025-01-28
- Last updated
- 2025-03-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06795594. Inclusion in this directory is not an endorsement.